Founded with a mission to improve lives and environments, Vystar is a publicly-traded biotechnology company specializing in the rubber and plastic products market. The company's core innovation, Vytex Natural Rubber Latex, significantly reduces antigenic proteins and non-rubbers to undetectable levels, making it safer for users prone to latex allergies. Vystar offers a range of products including natural rubber latex and clinical sleep diagnostics equipment, focusing on enhancing safety and comfort in medical and consumer goods.
Notable affiliates include key investors and industry experts who have supported Vystar's growth and innovation. The company has achieved significant milestones, such as the successful commercialization of Vytex latex in various products like condoms, which meet the growing demand for hypoallergenic materials. Vystar's impact is evident in its contribution to safer medical supplies and consumer products, positioning it as a leader in biotechnology-driven solutions for the rubber and plastic industry.
